PD-0325901

PD-0325901 

To Order Contact us: lieven@wlsolutions.be

PD 0325901
GL5463-1	1	EUR 68.9

PD 0325901
GL5463-25	25	EUR 228.1

PD 0325901
GL5463-5	5	EUR 98.4

PD 0325901
MBS132263-100mg	100mg	EUR 1065

PD 0325901
MBS132263-500mg	500mg	EUR 2775

PD 0325901
MBS696352-10mg	10mg	EUR 215

PD 0325901
MBS696352-25mg	25mg	EUR 325

PD 0325901
MBS696352-5x25mg	5x25mg	EUR 1410

EZSolution? PD-0325901, Sterile-Filtered
1990-1	each	EUR 326.4

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-10mg	10(mg	EUR 255

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-25mg	25mg	EUR 450

PD-325901, Free Base (PD 0325901, MEK1/2 Inhibitor III)
MBS6061791-5x25mg	5x25mg	EUR 1865

PD150606 (PD 150606; PD-150606)
MBS131512-100mg	100mg	EUR 1495

PD 312236, PD 312237 Mixture
P217850	10mg	EUR 230

PD-1/PD-L1 Inhibitor 2
B1050-25	each	EUR 679.2

PD-1/PD-L1 Inhibitor 2
B1050-5	each	EUR 242.4

PD-1/PD-L1 Inhibitor 1
B1213-25	each	EUR 679.2

PD-1/PD-L1 inhibitor 2
B6023-25	25 mg	EUR 268
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 inhibitor 2
B6023-5	5 mg	EUR 84
Description: Apoptosis|PD-1/PD-L1 interaction#Apoptosis

PD-1/PD-L1 inhibitor 1
B6172-25	25 mg	EUR 278.4
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1 inhibitor 1
B6172-5	5 mg	EUR 82.4
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1 Inhibitor 3
B6191-1	1 mg	EUR 248.8
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1 Inhibitor 3
B6191-5	5 mg	EUR 837.6
Description: Apoptosis|PD-1/PD-L1 interaction

PD-1/PD-L1-IN-29
HY-152240	1 mg	EUR 919.93
Description: PD-1/PD-L1-IN-29 (S4-1) is a potent PD-1/PD-L1 inhibitor with an IC50 value of 6.1 nM. PD-1/PD-L1-IN-29 binds PD-L1 and disrupts PD-1/PD-L1 interactions, induces PD-L1 dimerization and internalization, improves its localization to the endoplasmic reticulum, and promotes PD-L1 entry into the endoplasmic reticulum. PD-1/PD-L1-IN-29 has anticancer activity[1].

PD-1/PD-L1-IN-31
HY-149356	Get quote	Ask for price
Description: PD-1/PD-L1-IN-31 is a PD-1/PD-L1 inhibitor (IC50=2.2 nM). PD-1/PD-L1-IN-31 promotes secretion of the IFN-γ, and induces immune activity of peripheral blood mononuclear cells (PBMCs) to inhibits tumor cells[1].

PD-1/PD-L1-IN 3
HY-103048	Get quote	Ask for price
Description: PD-1/PD-L1-IN 3, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and CD80/PD-L1 interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC50s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 can be used for the research of various diseases, including cancer and infectious diseases[1].

PD-1/PD-L1-IN-34
HY-154869	Get quote	Ask for price
Description: PD-1/PD-L1-IN-34 (Compound (1S,2S)-A25) inhibits PD-1/PD-L1 interaction (IC50=0.029 μM), with a selected binding affinity with PD-L1 (KD=0.1554 μM). PD-1/PD-L1-IN-34 inhibits tumor growth by activating the immune microenvironment[1].

PD-1/PD-L1-IN-32
HY-155740	Get quote	Ask for price
Description: PD-1/PD-L1-IN-32 (compound A56) is a potent PD-1/PD-L1 inhibitor (IC50=2.4 nM), with anticancer activity. PD-1/PD-L1-IN-32 significantly inhibits tumor growth in hPD-L1 MC38 humanized mouse model, without obvious toxicity against mouse normal ability[1].

PD-1/PD-L1-IN-33
HY-155959	10 mg	EUR 1623.4
Description: PD-1/PD-L1-IN-33 (Compound N11) is a PD-1/PD-L1 inhibitor. PD-1/PD-L1-IN-33 inhibits PD-1 and PD-L1 interaction with an IC50: 6.3 nM. PD-1/PD-L1-IN-33 promotes T-cell proliferation, activation, and infiltration into tumor spheres. PD-1/PD-L1-IN-33 has immunomodulatory and anticancer activity[1].

PD-1/PD-L1-IN-36
HY-163041	Get quote	Ask for price
Description: PD-1/PD-L1-IN-36 (Compound 2k) is a PD-1/PD-L1 complex inhibitor (IC50: 15 nM). PD-1/PD-L1-IN-36 can be used for research of cancer immunotherapy[1].

PD-1/PD-L1-IN 5
HY-129172A	Get quote	Ask for price
Description: PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1].

PD-1/PD-L1-IN 6
HY-130625	Get quote	Ask for price
Description: PD-1/PD-L1-IN 6 (compound A13) is a potent PD-1/PD-L1 interaction inhibitor, with an IC50 of 132.8 nM. PD-1/PD-L1-IN 6 exhibits outstanding immunoregulatory activity. PD-1/PD-L1-IN 6 significantly elevates interferon-γ secretion in a Hep3B/OS-8/hPD-L1 and CD3 T cell co-culture model, without significant toxic effect. PD-1/PD-L1-IN 6 restores the immune response in a T cell-tumor co-culture model[1].

PD-1/PD-L1-IN-NP19
HY-131347	10 mg	EUR 1948.08
Description: PD-1/PD-L1-IN-NP19 is a PD-1/PD-L1 inhibitor, with an IC50 of 12.5 nM for human PD-1/PD-L1 interaction. PD-1/PD-L1-IN-NP19 could activate the immune microenvironment in tumor, which may contribute to its antitumor effects[1].

PD-1/PD-L1-IN-9
HY-132192	10 mg	EUR 984.86
Description: PD-1/PD-L1-IN-9 is a potent and orally active inhibitor of PD-1/PD-L1 interaction, with an IC50 of 3.8 nM. PD-1/PD-L1-IN-9 can enhance the killing activity of tumor cells by immune cells. PD-1/PD-L1-IN-9 also exhibits significant in vivo antitumor activity in a CT26 mouse model[1].

PD-1/PD-L1-IN-10
HY-132202	10 mg	EUR 779.23
Description: PD-1/PD-L1-IN-10 (compound B2) is an orally active PD-1/PD-L1 inhibitor (IC50 of 2.7 nM) with potent anticancer efficacy[1].

PD-1/PD-L1-IN-13
HY-145239	1 mg	EUR 3517.37
Description: PD-1/PD-L1-IN-13 (Compound 43) is a potent immune checkpoint PD-1/PD-L1 inhibitor with an IC50 value of 10.2 nM. PD-1/PD-L1-IN-13 promots CD8+ T cell activation and delays the tumor growth in the Hepa1-6 syngeneic mouse model[1].

PD-1/PD-L1-IN-18
HY-145768	Get quote	Ask for price
Description: PD-1/PD-L1-IN-18 (Compound L31) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-18 blocks PD-1/PD-L1 with the IC50 of 1.054 μM. Antitumor Activity[1].

PD-1/PD-L1-IN-19
HY-145770	Get quote	Ask for price
Description: PD-1/PD-L1-IN-19 (Example 22) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-19 blocks PD-1/PD-L1 with the IC50 of 62.3 nM. PD-1/PD-L1-IN-19 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-20
HY-145771	Get quote	Ask for price
Description: PD-1/PD-L1-IN-20 (Example 21) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-20 blocks PD-1/PD-L1 with the IC50 of 5.29 nM. PD-1/PD-L1-IN-20 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-21
HY-145772	Get quote	Ask for price
Description: PD-1/PD-L1-IN-21 (Example 22) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-21 blocks PD-1/PD-L1 with the IC50 of 4.99 μM. PD-1/PD-L1-IN-21 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-22
HY-145773	Get quote	Ask for price
Description: PD-1/PD-L1-IN-22 (Example 2) is a small-molecule inhibitor of the PD-1/PD-L1 protein-protein interaction. PD-1/PD-L1-IN-22 blocks PD-1/PD-L1 with the IC50 of 0.732 μM. PD-1/PD-L1-IN-22 can be used for the research of cancers, infectious diseases and autoimmune diseases[1].

PD-1/PD-L1-IN-23
HY-145774	10 mg	EUR 4058.51
Description: PD-1/PD-L1-IN-23 is a potent and orally active inhibitor of PD-1/PD-L1. PD-1/PD-L1-IN-23 is an ester proagent of L7. L7 is a benzo[c][1,2,5]oxadiazole derivative and biologically evaluated as inhibitors of PD-L1. PD-1/PD-L1-IN-23 displays significant antitumor effects in tumor models of syngeneic and PD-L1 humanized mice[1].

PD-1/PD-L1-IN-27
HY-146740	Get quote	Ask for price
Description: PD-1/PD-L1-IN-27 is a potent PD-1/PD-L1 inhibitor with an IC50 value of 134 nM. PD-1/PD-L1-IN-27 shows antitumor effects with low T cell cytotoxicity. PD-1/PD-L1-IN-27 has the ability to activate CD8+ T cells and reduces T cell exhaustion[1].

PD-1/PD-L1-IN-28
HY-148305	Get quote	Ask for price
Description: PD-1/PD-L1-IN-28 (compound 3) is an immune checkpoint inhibitor of PD-1/PD-L1 signaling pathway (IC50=0.744 µM). PD-1/PD-L1-IN-28 shows good research potential in tumor immunity[1].

PD-1/PD-L1-IN-25
HY-143305	Get quote	Ask for price
Description: PD-1/PD-L1-IN-25 (compound D2) is an inhibitor of PD-1/PD-L1 interaction with an IC50 value of 16.17 nM. PD-1/PD-L1-IN-25 activates the antitumor immunity of T cells efficiently in PBMCs. PD-1/PD-L1-IN-25 can be used for the research of cancer[1].

PD-1/PD-L1-IN-14
HY-144258	10 mg	EUR 2543.33
Description: PD-1/PD-L1-IN-14 (compound 17) is a bifunctional inhibitor of PD-1/PD-L1 interactions, with an IC50 of 27.8 nM. PD-1/PD-L1-IN-14 (compound 17) inhibits PD-1/PD-L1 interactions and promotes dimerization, internalization, and degradation of PD-L1[1].

PD-1/PD-L1-IN-15
HY-144442	Get quote	Ask for price
Description: PD-1/PD-L1-IN-15 (Compound M17) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 60.1 nM. PD-1/PD-L1-IN-15 has the potential for the research of tumor immunoresearch[1].

PD-1/PD-L1-IN-16
HY-144443	Get quote	Ask for price
Description: PD-1/PD-L1-IN-16 (Compound M23) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 53.2 nM. PD-1/PD-L1-IN-16 has the potential for the research of tumor immunoresearch[1].

PD-1/PD-L1-IN-17
HY-144447	Get quote	Ask for price
Description: PD-1/PD-L1-IN-17 (Compound P20) is a potent inhibitor of PD-1/PD-L1 with an IC50 value of 26.8 nM. PD-1/PD-L1-IN-17 is a promising lead compound for the development of inhibitors of the PD-1/PD-L1 interaction. PD-1/PD-L1-IN-17 has the potential for the research of cancer diseases[1].

PD-1/PD-L1-IN-24
HY-144649	Get quote	Ask for price
Description: PD-1/PD-L1-IN-24 is a highly potent PD-1/PD-L1 inhibitor with IC50 value of 1.57 nM. PD-1/PD-L1-IN-24 can restore T-cell function at the cellular level by significantly elevating the IFN-γ level. PD-1/PD-L1-IN-24 has low toxicity on the PBMCs[1].

PD-1/PD-L1-IN-26
HY-144746	Get quote	Ask for price
Description: PD-1/PD-L1-IN-26 (Compound II-14) is a potent inhibitor of PD-1/PD-L1 with an IC50 of 0.0380 μM. PD-1/PD-L1-IN-26 activates the immune microenvironment by promoting the infiltration of CD4+ T cells into tumor tissues. PD-1/PD-L1-IN-26 has the potential for the research of cancer diseases[1].

PD-1/PD-L1-IN-NP19
MBS5785098-10mg	10mg	EUR 555

PD-1/PD-L1-IN-NP19
MBS5785098-25mg	25mg	EUR 1350

PD-1/PD-L1-IN-NP19
MBS5785098-50mg	50(mg	EUR 1520

PD-1/PD-L1-IN-NP19
MBS5785098-5mg	5(mg	EUR 375

PD-1/PD-L1 inhibitor 1
MBS578522-10mg	10mg	EUR 250

PD-1/PD-L1 inhibitor 1
MBS578522-25mg	25mg	EUR 375

PD-1/PD-L1 inhibitor 1
MBS578522-2mg	2mg	EUR 160

PD-1/PD-L1 inhibitor 1
MBS578522-50mg	50mg	EUR 510

PD-1/PD-L1 inhibitor 1
MBS578522-5mg	5mg	EUR 190

PD-1/PD-L1-IN-10
MBS5786462-10mg	10(mg	EUR 250

PD-1/PD-L1-IN-10
MBS5786462-2mg	2(mg	EUR 180

PD-1/PD-L1-IN-10
MBS5786462-5mg	5(mg	EUR 195

PD-1/PD-L1-IN-9
MBS5801395-1mg	1(mg	EUR 225

PD-1/PD-L1-IN-9
MBS5801395-2mg	2mg	EUR 285

PD-1/PD-L1-IN-9
MBS5801395-5mg	5(mg	EUR 345

PD-1/PD-L1-IN-16
T63948-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-16
T63948-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-16

PD-1/PD-L1-IN-20
T64086-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-20
T64086-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-20

PD-1/PD-L1-IN-10
T9616-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-10
T9616-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-10

PD-1/PD-L1-IN-9
T9651-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-9
T9651-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-9

PD-1/PD-L1-IN-NP19
T36900-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-NP19
T36900-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-NP19

PD-1/PD-L1-IN-14
T61929-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN-14
T61929-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-14

PD-1/PD-L1-IN 6
T61968-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-1g	1g	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 6
T61968-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN 6

PD-1/PD-L1-IN 5
T62193-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-1g	1g	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN 5
T62193-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN 5

PD-1/PD-L1-IN-17
T62501-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-17
T62501-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-17

PD-1/PD-L1-IN-25
T63329-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-25
T63329-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-25

PD-1/PD-L1-IN-22
T63607-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-22
T63607-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-22

PD-1/PD-L1-IN-15
T63614-10mg	10mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-1g	1g	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-1mg	1mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-50mg	50mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD-1/PD-L1-IN-15
T63614-5mg	5mg	Ask for price
Description: PD-1/PD-L1-IN-15

PD 150606
A4413-10	10mg	EUR 145.6
Description: Proteases|Calpains

PD 150606
A4413-25	25 mg	EUR 304
Description: Proteases|Calpains

PD 150606
A4413-5	5 mg	EUR 87.2
Description: Proteases|Calpains

PD 150606
A4413-50	50mg	EUR 542.4
Description: Proteases|Calpains

PD 166793
A4438-10	10 mg	EUR 188
Description: Proteases|MMP

PD 166793
A4438-25	25 mg	EUR 432
Description: Proteases|MMP

PD 166793
A4438-5	5 mg	EUR 224.4
Description: Broad spectrum MMP inhibitor. Displays high affinity for MMP-2, -3 and -13 (IC50 values are 4, 7 and 8 nM respectively) and exhibits > 750-fold selectivity over MMP-1, -7 and -9. Attenuates left ventricular remodelling and dysfunction in rat model of heart failure.

PD 166793
A4438-50	50mg	EUR 730
Description: MMP inhibitor

PD 180970
A8606-10	10 mg	EUR 344
Description: TGF-β / Smad Signaling|Bcr-Abl#Tyrosine Kinase|Bcr-Abl

PD 169316
A8689-10	10 mg	EUR 72
Description: MAPK Signaling|p38

PD 169316
A8689-5.1	10 mM (in 1mL DMSO)	EUR 105.6
Description: MAPK Signaling|p38

PD 169316
A8689-50	50 mg	EUR 271.2
Description: MAPK Signaling|p38

PD 173074
A8253-10	10 mg	EUR 40
Description: Tyrosine Kinase|FGFR#Tyrosine Kinase|VEGFR

PD 173074
A8253-5.1	10 mM (in 1mL DMSO)	EUR 48
Description: Tyrosine Kinase|FGFR#Tyrosine Kinase|VEGFR

PD 173074
A8253-50	50 mg	EUR 112
Description: Tyrosine Kinase|FGFR#Tyrosine Kinase|VEGFR

PD 173074
A8253-S	Evaluation Sample	EUR 24
Description: Tyrosine Kinase|FGFR#Tyrosine Kinase|VEGFR

PD-166285
525796	5.0mg	EUR 275

PD 109488
525816	50.0mg	EUR 1340

PD 135158
525842	10.0mg	EUR 390

PD-176252
525902	10.0mg	EUR 400

PD-198306
525904	5.0mg	EUR 410

PD 146176
530393	10.0mg	EUR 250

PD 150606
531245	200.0mg	EUR 950

PD-85639
531389	5.0mg	EUR 250

PD-156707
532448	5.0mg	EUR 265

PD 158780
532449	10.0mg	EUR 470

PD 168368
532455	5.0mg	EUR 350

PD 117519
585228	5.0mg	EUR 230

PD-173212
598025	5.0mg	EUR 375

PD-166793
598116	10.0mg	EUR 360

PD-118057
561213	5.0mg	EUR 330

PD 124966
414279	500.0µg	EUR 355

PD-0325901